Henry Schein Raises 2026 Financial Outlook as Sales Growth and Profitability Strengthen
Henry Schein has raised its financial outlook for fiscal 2026 after delivering a strong second quarter marked by broad-based revenue growth, improved profitability and continued momentum across its dental, medical, specialty and technology businesses.
The company’s latest results indicate that its strategic initiatives are beginning to translate into stronger operating performance, while ongoing investments in technology, customer relationships and operational efficiency are supporting growth across its global business. Following a solid first half of the year, management expressed increased confidence in its ability to maintain momentum through the remainder of 2026.
For the second quarter, Henry Schein generated $3.5 billion in net sales, representing a 6.7% increase compared with the same period in 2025. The increase was supported by 4.6% internal sales growth, contributions from acquisitions and favorable foreign currency exchange.
The company also reported improvements in profitability, with both GAAP and non-GAAP earnings increasing during the quarter. The results helped strengthen management’s confidence in the company’s full-year performance and led Henry Schein to raise its 2026 financial guidance.
Strong Second-Quarter Sales Across Key Businesses
Henry Schein’s second-quarter performance was supported by growth across several of its major business areas.
Global Dental Distribution merchandise sales increased 9.7%, demonstrating continued demand across the company’s core dental distribution operations. Dental remains a central component of Henry Schein’s global business, serving dental practices, laboratories, healthcare providers and other customers with a broad portfolio of products and services.
Equipment sales also increased during the quarter, rising 3.8% compared with the second quarter of 2025. Equipment represents an important part of Henry Schein’s offering as dental and healthcare providers continue investing in modern technologies, practice infrastructure and clinical capabilities.
The company’s Specialty Products segment delivered particularly strong results, with sales increasing 8.7%. Specialty businesses provide Henry Schein with opportunities to participate in healthcare areas that require specialized products, services and expertise.
The Technology segment also continued to perform well, recording an 8.2% increase in sales. Technology has become increasingly important to healthcare providers as practices seek to improve operational efficiency, patient engagement, data management and clinical workflows.
The broad-based nature of the quarterly growth suggests that Henry Schein is benefiting from demand across multiple areas rather than relying on a single business category.
Internal Growth Remains an Important Driver
Henry Schein reported 4.6% internal sales growth for the quarter. Internal growth is an important indicator because it reflects the underlying performance of the company’s existing operations, excluding the impact of acquisitions and other external factors.
The company’s total sales growth of 6.7% was therefore supported by a combination of organic business momentum, acquisitions and favorable currency movements.
For a global healthcare distributor and solutions provider, maintaining consistent internal growth can be particularly important. The company operates across multiple markets and serves a diverse customer base, meaning performance can be influenced by healthcare spending, customer demand, product availability, economic conditions and currency movements.
The latest results indicate that Henry Schein continues to generate underlying demand while also benefiting from its broader strategic portfolio.
Profitability Improves in the Second Quarter
Revenue growth was accompanied by improved profitability.
Henry Schein reported GAAP net income of $94 million, equivalent to $0.82 per diluted share. On a non-GAAP basis, net income reached $145 million, or $1.27 per diluted share.
The difference between GAAP and non-GAAP results reflects adjustments for certain items that management excludes when assessing underlying operating performance. Non-GAAP results are commonly used by companies to provide investors with a view of ongoing business performance that excludes certain unusual or non-recurring effects.
The company also reported adjusted EBITDA of $288 million.
The improvement in adjusted EBITDA reflects the benefits of higher sales, operating discipline and continued progress with efficiency initiatives. Stronger profitability is particularly important as Henry Schein continues to invest in growth areas while also pursuing opportunities to simplify its operations.
Operational Efficiency Supports Long-Term Strategy
Henry Schein has been implementing operational initiatives designed to improve efficiency and create sustainable value.
Management has emphasized several priorities, including accelerating growth, simplifying operations, strengthening customer relationships and improving shareholder value.
Operational efficiency can play a significant role in a distribution and technology-driven healthcare business. Companies operating across multiple markets must manage complex supply chains, inventory, logistics, technology systems and customer service operations.
Improving these processes can help organizations reduce unnecessary costs, improve service levels and allocate resources more effectively.
The increase in adjusted EBITDA during the second quarter suggests that Henry Schein is beginning to see benefits from these efforts.
Rather than focusing solely on revenue expansion, the company is working to ensure that growth translates into stronger margins and sustainable earnings.
Share Repurchases Demonstrate Capital Allocation Confidence
During the quarter, Henry Schein repurchased approximately 2.6 million shares of common stock for $200 million.
Share repurchases represent one component of the company’s capital allocation strategy. By purchasing shares, a company can return capital to shareholders while potentially reducing the number of shares outstanding and increasing earnings per share over time.
The size of the second-quarter repurchase program also reflects management’s confidence in the company’s financial position and future prospects.
Combined with investments in organic growth, acquisitions and technology, share repurchases form part of Henry Schein’s broader approach to creating long-term shareholder value.
CEO Highlights Continued Business Momentum
Fred Lowery, CEO of Henry Schein, said the company’s second-quarter performance reflects sustained business momentum and disciplined execution.
Management remains focused on accelerating growth while simplifying operations and strengthening relationships with customers.
Customer relationships are particularly important in healthcare distribution because providers depend on reliable access to medical and dental products. Consistent product availability, efficient delivery, technology integration and responsive service can influence customer loyalty and long-term business performance.
Henry Schein’s diversified business model allows it to provide customers with products as well as technology and specialized solutions. This creates opportunities to develop deeper relationships with healthcare professionals and support them across multiple aspects of their operations.
Technology Becomes an Increasingly Important Growth Area
The company’s 8.2% growth in its Technology segment highlights the increasing importance of digital solutions within healthcare.
Dental and medical practices are increasingly using technology to manage scheduling, billing, patient records, imaging, communication and other administrative and clinical processes.
Technology can also help healthcare providers improve operational efficiency and enhance the patient experience.
For Henry Schein, expanding technology capabilities provides an opportunity to move beyond traditional distribution and establish itself as a broader solutions provider.
The company’s technology portfolio can complement its distribution activities by helping customers manage their businesses more efficiently.
As healthcare providers continue to digitize their operations, demand for integrated technology solutions could provide an additional source of long-term growth.
Specialty Products Continue to Expand
The Specialty Products segment’s 8.7% sales increase also demonstrates the strength of Henry Schein’s diversified strategy.
Specialty healthcare markets often have distinct product requirements and customer needs. By maintaining dedicated capabilities in specialty areas, Henry Schein can participate in markets that may experience different growth patterns from its core distribution operations.
Diversification across dental, medical, specialty and technology businesses can also help reduce the company’s reliance on any single market.
When one area experiences slower demand, stronger performance elsewhere can help support overall results.
The second-quarter numbers demonstrate the benefit of this diversified approach, with multiple business units contributing to growth.
Henry Schein Raises 2026 Financial Guidance
Following its strong first-half performance, Henry Schein increased its expectations for fiscal 2026.
The company now expects non-GAAP diluted earnings per share of $5.29 to $5.39 for the full year.
Henry Schein also expects total sales growth of approximately 4.5% to 5.5%.
In addition, management expects adjusted EBITDA growth in the mid- to high-single-digit range.
The revised guidance represents a stronger outlook for the company and reflects management’s confidence in continued operational execution.
Raising guidance following the second quarter indicates that the company believes the underlying trends supporting its performance can continue during the second half of the year.
Outlook Reflects Confidence in Business Fundamentals
The updated guidance also reflects expectations for continued strength across several of Henry Schein’s businesses.
Dental distribution remains a significant growth engine, while specialty products and technology provide additional opportunities.
The company is also expected to continue benefiting from its efficiency initiatives, which are designed to improve profitability and create a more streamlined operating structure.
Acquisitions remain another potential source of growth. Henry Schein has historically used acquisitions to expand its product portfolio, geographic reach and capabilities.
However, the company’s latest results suggest that organic growth and operational improvements are also playing an important role in its current performance.
Healthcare Market Trends Support Demand
Henry Schein’s performance comes at a time when healthcare providers continue to invest in products, equipment and technology.
Dental practices, medical providers and specialty healthcare organizations require reliable access to supplies and equipment to maintain day-to-day operations.
At the same time, providers are increasingly focused on productivity and cost management. Technology can help practices automate administrative tasks, improve workflow management and make better use of data.
These trends create opportunities for companies such as Henry Schein that can combine distribution capabilities with technology and specialized services.
Focus on Sustainable Value Creation
Beyond its quarterly results, Henry Schein’s strategy remains focused on creating sustainable long-term value.
The company is seeking to balance several priorities: expanding revenue, improving margins, investing in technology, strengthening customer relationships, pursuing strategic acquisitions and returning capital to shareholders.
The latest financial results indicate progress across several of these areas.
Sales growth accelerated across major segments, profitability improved and share repurchases continued. At the same time, management raised its full-year earnings and sales expectations.
This combination provides a stronger foundation for Henry Schein’s outlook for the remainder of 2026.
Strong First Half Sets Stage for Second Half
The second quarter represents another important step in Henry Schein’s 2026 performance. The company’s $3.5 billion in quarterly sales, broad-based segment growth and improved profitability demonstrate continued business momentum.
The increase in Global Dental Distribution merchandise sales, Specialty Products and Technology revenue indicates that demand is not concentrated in a single business line. Meanwhile, the improvement in adjusted EBITDA points to progress in translating revenue growth into stronger operating performance.
With the company now expecting 4.5% to 5.5% sales growth and non-GAAP diluted earnings per share of $5.29 to $5.39 for the full year, management enters the second half of 2026 with increased confidence.
Henry Schein’s focus on operational efficiency, technology, customer relationships and disciplined capital allocation will remain central to its strategy.
As healthcare providers continue to seek efficient, technology-enabled solutions and reliable access to products, Henry Schein is positioned to benefit from the evolving needs of the dental and medical markets.
The company’s decision to raise its 2026 financial outlook ultimately signals confidence that the positive trends seen during the first half of the year can continue. With growth across its core businesses, improving profitability and ongoing strategic initiatives, Henry Schein is entering the second half of the year with a stronger financial position and a renewed focus on sustainable growth and long-term value creation.
Source link: https://www.dentistry33.com/
